s.ivaturi

TL2 · Turku

Contributes reviews on supplier material. Based in Turku.

Joined 5 May 2025 · last posted 19d

81 posts, newest first. Showing up to 150.

A critique that turned out to be unfair, retracted by its author Replied, post #27 · Evidence › Study critique · 9 Jul 2026 · 0 likes Picking up post #26: that is the part I would want checked first. Where a critique rests on a subgroup, check whether the interaction was tested. A difference between…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #117 · Practice › Reconstitution · 9 Jul 2026 · 0 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
Why we ask for units every single time, with three examples of what goes wrong Replied, post #111 · Start Here › How to Ask · 9 Jul 2026 · 6 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
Sulfonylureas: the interaction most worth taking seriously Replied, post #8 · Practice › Interactions · 5 Jul 2026 · 16 likes Oral medications with a narrow therapeutic index are the ones where that matters most. The interaction is about rate and timing rather than about the total absorbed, in…
Journal club: what we got wrong in an earlier session Replied, post #27 · Evidence › Journal club · 25 Jun 2026 · 22 likes Adding the measurement that post #24 says would settle it. The baseline characteristics table is the single most useful page for the questions that get asked here,…
What steady state means for the decision to escalate Replied, post #18 · Practice › Dosing & titration · 24 Jun 2026 · 17 likes Small correction to my own earlier position on steady state. I had the units the wrong way round, which changes the conclusion by an order of magnitude and therefore…
Research-use-only status: what it means legally and practically Replied, post #60 · Compounds › Other compounds · 18 Jun 2026 · 12 likes Several compounds discussed here have no published human pharmacokinetics at all. That means half-life claims in circulation were derived from an animal model or from…
CJC-1295 with and without DAC: what the modification does Replied, post #86 · Compounds › Secretagogues & GH axis · 17 Jun 2026 · 5 likes Post #84 and I disagree about the size of the effect, not about the direction. A mass result for a short peptide is more discriminating than for a long one, because a…
Transporting a vial for a weekend away — a second dataset Replied, post #80 · Practice › Storage & stability · 12 Jun 2026 · 18 likes Worth separating two things that post #78 runs together. The honest answer on Transporting a vial is that it depends, and the useful part is the list of what it depends…
Tracking a shortage from primary sources rather than rumour Replied, post #44 · Access › Shortages · 10 Jun 2026 · 22 likes Post #42 is the version of this I will quote in future. One addition. Both are useful and different. The notice tells you the national position; the account tells you…
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #36 · Analytics › Mass spectrometry · 9 Jun 2026 · 0 likes Picking up post #35: that is the part I would want checked first. Tandem mass spectrometry with fragmentation gives sequence information that intact mass cannot. It is…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #73 · Practice › Reconstitution · 6 Jun 2026 · 28 likes That is a cleaner way of putting what I was circling around.
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #3 · Compounds › Cagrilintide & amylin analogues · 31 May 2026 · 14 likes The most useful reply I ever got about cagrilintide alone was a request to state my units. It sounds like pedantry and it has saved me twice.
A site rotation scheme that is easy enough to actually follow Replied, post #64 · Practice › Administration · 16 May 2026 · 26 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
Prescription requirements and telehealth models — a second dataset Replied, post #25 · Sourcing › Regulatory · 10 May 2026 · 1 like Worth separating Prescription requirements and telehealth models as a question about the compound from Prescription requirements and telehealth models as a question…
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #32 · Analytics › COA interpretation · 3 May 2026 · 0 likes Reading this field-by-field walk through a certificate thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #106 · Practice › Storage & stability · 28 Apr 2026 · 14 likes Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to…
Sample handling between despatch and injection Replied, post #67 · Analytics › Method validation · 25 Apr 2026 · 0 likes Sample stability during analysis is part of validation and is routinely ignored. A preparation that degrades in the autosampler over eight hours produces a…
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #108 · Analytics › Mass spectrometry · 23 Apr 2026 · 1 like Post #106 answers the question as asked. The question underneath it is different. Positional isomers and epimers are mass-identical. Any argument that a mass result…
Official shortage notices and what they authorise Replied, post #14 · Access › Shortages · 20 Apr 2026 · 19 likes This follows post #13 rather than contradicting it. Pharmacy-level availability varies enormously during a shortage, so two honest accounts from the same city can be…
Anaesthesia and elective surgery: the aspiration question Replied, post #91 · Practice › Interactions · 18 Apr 2026 · 0 likes Where I part company with post #90, and it is a narrow parting. Adding a reference point for anaesthesia and elective surgery. Mine is a single case, collected without…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #148 · Access › Pricing · 16 Apr 2026 · 24 likes I had written a reply contradicting post #146 and deleted it. Here is what survived. Counterpoint on Price changes, offered without confidence: the same observation is…
Fasting versus non-fasting and which tests care Replied, post #5 · Clinical › Bloodwork · 29 Mar 2026 · 7 likes Fasting versus non-fasting: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #58 · Research Methods › N-of-1 designs · 25 Mar 2026 · 0 likes Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores) increase the power to detect a real effect even though n=1. The…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #96 · Lounge › Introductions · 17 Mar 2026 · 0 likes No judgment: people come to this community from all backgrounds and with all motivations. Introductions are for getting to know each other, not for evaluation.
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #73 · Start Here › How to Ask · 13 Mar 2026 · 2 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
Reading a regulatory notice rather than an article about it Replied, post #3 · Sourcing › Regulatory · 10 Mar 2026 · 4 likes Date every claim in this subcategory. A regulatory position stated without a date is worse than no claim, because it will be read as current indefinitely.
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #126 · Compounds › Semaglutide · 22 Feb 2026 · 0 likes Posting my semaglutide half-life numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
Micro-titration: a disputed topic, argued properly — one year on Replied, post #3 · Practice › Dosing & titration · 6 Feb 2026 · 25 likes A titration plan written down in advance is easier to stick to and easier to abandon deliberately. An improvised one becomes a series of decisions made on the worst day…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #9 · Evidence › Study critique · 27 Jan 2026 · 0 likes On post #5 — agreed on the reasoning, with one qualification. Surrogate endpoints are not automatically bad and their validity is compound-specific and…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #59 · Access › International · 17 Jan 2026 · 0 likes My experience of Language barriers in accessing contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's…
Muscle cramps: the ordinary causes before the exotic ones Replied, post #42 · Practice › Side effects · 16 Jan 2026 · 31 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Solubility limits and what a cloudy solution is telling you Started this topic · Pharmacology › Formulation chemistry · 28 Dec 2025 · 0 likes Solubility limits and what a cloudy solution is telling you — setting out what I have, and where I think it stops being reliable. The question about solubility limits…
Why oral semaglutide needs an absorption enhancer at all Replied, post #60 · Compounds › Oral incretins · 20 Dec 2025 · 1 like Coming back to post #56, because the follow-up matters more than the original answer. Dose numbers for oral formulations are not comparable to injectable ones. The 14…
Journal club: LEADER as the historical anchor Replied, post #8 · Evidence › Journal club · 30 Nov 2025 · 12 likes Narrowing post #5, because the general version has more than one answer. The most common failure mode is spending fifty minutes on the effect size and ten on the…
Waist circumference technique and its repeatability Replied, post #18 · Outcomes › Progress reports · 20 Nov 2025 · 0 likes Distinguishing three things in the waist circumference technique discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the…
Where the integrator drew the baseline, and how much it moved the number Replied, post #20 · Analytics › HPLC & UHPLC · 15 Nov 2025 · 0 likes Worth separating two things that post #18 runs together. On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #29 · Clinical › Special populations · 11 Nov 2025 · 18 likes Coming back to post #27, because the follow-up matters more than the original answer. Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical…
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #3 · Data & Tools › Calculators · 7 Nov 2025 · 0 likes Offline use: all calculators are written in JavaScript and can be downloaded and run offline if desired. They do not require internet connectivity to function. The…
Follow-up: Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #11 · Practice › Dosing & titration · 13 Oct 2025 · 11 likes Dose and effect are not linear across the studied range for every compound in this class. Assuming a doubled dose gives a doubled effect is the reasoning error behind…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #103 · Evidence › Study critique · 15 Sep 2025 · 13 likes A run-in period that excludes non-responders before randomisation changes what the trial is estimating. It is legitimate design and it must be stated in any summary.
Payment method and the leverage it gives you, ranked Replied, post #13 · Sourcing › Payments · 15 Sep 2025 · 11 likes Payment method has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #28 · Analytics › Method validation · 2 Sep 2025 · 0 likes I would rather this thread reach "we do not know" about LOD and LOQ than reach a confident answer that nobody can support when asked.
Distinguishing a deletion sequence by mass alone — the long version Replied, post #44 · Analytics › Mass spectrometry · 29 Aug 2025 · 32 likes On post #40 — agreed on the reasoning, with one qualification. Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large…
What a documentation review can and cannot tell you Replied, post #79 · Sourcing › Independent verification · 19 Aug 2025 · 17 likes Post #75 and I disagree about the size of the effect, not about the direction. Repeat testing: if you want to verify the same lot a second time, testing with a…
Which panel is worth repeating and which is worth ignoring Replied, post #85 · Clinical › Bloodwork · 15 Aug 2025 · 3 likes Answering the question post #81 raises rather than the one it answers. Panel is well covered in the tag pages, and the older discussions are better than the recent ones…
Follow-up: Why appetite effects are mostly central Replied, post #16 · Pharmacology › Receptor biology · 12 Aug 2025 · 30 likes Second-hand on appetite effects, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
[2026 update] Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA Replied, post #2 · Compounds › Tirzepatide · 11 Aug 2025 · 4 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
Coming back to: When "no data" is the complete and final answer Replied, post #80 · Compounds › Other compounds · 11 Aug 2025 · 2 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
A request that was declined, and the reasoning — a second dataset Replied, post #18 · Documentation › Wiki requests · 7 Aug 2025 · 22 likes Request a new maintained page: if a question recurs, has a good marked solution, and contains a worked example, it is a candidate for promotion to a maintained…
Antibiotics and a course of something with delayed emptying Replied, post #100 · Practice › Interactions · 25 Jul 2025 · 12 likes Alcohol is not contraindicated in the labelling and it does irritate a stomach that is already emptying slowly. There is no published interaction study, and the…
A field-by-field walk through a certificate of analysis Replied, post #104 · Analytics › COA interpretation · 17 Jul 2025 · 10 likes On field-by-field walk through a certificate the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #29 · Practice › Reconstitution · 7 Jul 2025 · 2 likes Everything in post #25 holds. The case it does not cover is the one I have. If your arithmetic gives a volume smaller than one graduation on your syringe, the answer is…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #65 · Evidence › Trials · 30 Jun 2025 · 0 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #25 · Analytics › Method validation · 27 Jun 2025 · 0 likes I would rather this thread reach "we do not know" about Forced degradation studies than reach a confident answer that nobody can support when asked.
Titles that describe the question, not the situation Replied, post #28 · Start Here › How to Ask · 14 Jun 2025 · 26 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
Validating a calculator against hand arithmetic — what changed since Replied, post #97 · Data & Tools › Calculators · 28 May 2025 · 0 likes A calculator that shows its working is worth ten that give an answer. The whole value is being able to see which step you disagree with. I would rather be precise about…
Payment mechanics and the recovery options that do not exist — what changed since Replied, post #8 · Sourcing › Payments · 8 May 2025 · 25 likes Post #4 put the caveat in the right place and I want to underline it. Payment mechanics is well covered in the tag pages, and the older discussions are better than the…
Coming back to: Oxidation pathways for methionine and tryptophan Replied, post #6 · Analytics › Impurities & related substances · 6 May 2025 · 13 likes Confirming post #5 from a second method, which matters more than confirming it from a second person. Storage-related degradation and synthesis-related impurity look…
Titles that describe the question, not the situation Replied, post #3 · Start Here › How to Ask · 27 Apr 2025 · 3 likes The opening post describes the usual case. This is about the unusual one. It is fine to say you cannot explain why you are asking. Nobody will press, and the technical…
A report I filed that turned out to be wrong, and the correction Replied, post #24 · Sourcing › Vendor reports · 23 Apr 2025 · 0 likes Post #22 is right about the mechanism and I think understates the practical bit. The cost of a submission is worth stating. It is the main reason people do not do this…
Adjudicated events and why the definition matters — the long version Replied, post #80 · Evidence › Trials · 4 Apr 2025 · 0 likes Reframing Adjudicated events slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #141 · Sourcing › Regulatory · 5 Mar 2025 · 15 likes Answering the pharmaceutical compounding rules question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #22 · Evidence › Meta-analyses · 29 Jan 2025 · 0 likes I have no financial interest in anything named in this thread and I want to say so before I comment on Random versus fixed effects, because it is the sort of subject…
Why we hide unevidenced fraud accusations and log the hiding Replied, post #44 · Sourcing › Red flags · 26 Jan 2025 · 27 likes Answering the question post #42 raises rather than the one it answers. Where somebody posts a concern, ask what would resolve it before arguing about it. Half of these…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #29 · Compounds › Semaglutide · 16 Jan 2025 · 0 likes I changed my mind about published dose-response for semaglutide after someone here asked me for the source and I could not produce one. That is worth saying out loud…
UK access routes, dated and sourced — a second dataset Replied, post #27 · Regional › UK & Ireland · 15 Jan 2025 · 0 likes Correcting an out-of-date claim in this subcategory with a source and a date is more valuable than a new topic on the same question.
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #22 · Pharmacology › Receptor biology · 10 Jan 2025 · 0 likes Biased agonism was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #7 · Compounds › Semaglutide · 24 Dec 2024 · 18 likes Taking post #6 at face value and following it one step further. On dose steps: the four-week interval in the pivotal programme was a trial design choice, and slower…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #24 · Data & Tools › Calculators · 19 Dec 2024 · 24 likes Post #23 answers the question as asked. The question underneath it is different. Maintaining a calculator means checking the arithmetic against hand-worked cases at…
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #44 · Sourcing › Regulatory · 2 Dec 2024 · 1 like I would rather this thread reach "we do not know" about Research-use-only labelling than reach a confident answer that nobody can support when asked.
Washout with a one-week half-life: the arithmetic Replied, post #35 · Research Methods › N-of-1 designs · 29 Nov 2024 · 29 likes Adding a reference point for washout. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted appropriately.
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #41 · Clinical › Special populations · 23 Nov 2024 · 7 likes Everything in post #37 holds. The case it does not cover is the one I have. Type 1 diabetes would be much easier to settle if anyone reported the denominator. Almost…
Buffers, pH and why a formulation is a formulation Replied, post #14 · Pharmacology › Formulation chemistry · 30 Oct 2024 · 0 likes An honest declaration on buffers: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #4 · Compounds › Semaglutide · 29 Oct 2024 · 1 like I read post #2 twice before replying, because I had assumed the opposite. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology…
Irish differences from the UK position Replied, post #57 · Regional › UK & Ireland · 25 Oct 2024 · 1 like Summarising the irish differences thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the…
Why I ask for the gradient before I discuss the number Replied, post #23 · Analytics › HPLC & UHPLC · 26 Sep 2024 · 0 likes Post #19 describes the usual case. This is about the unusual one. Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and…
Reporting a discrepancy without making an allegation Replied, post #17 · Sourcing › Vendor reports · 6 Aug 2024 · 0 likes I have three months of notes on reporting a discrepancy and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the…
Guidelines revision: what changed and why Replied, post #119 · Meta › Announcements · 28 Jul 2024 · 0 likes On post #117 — agreed on the reasoning, with one qualification. The edit is clearer. For anyone arriving now, read the edited version — the confusion in the replies…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #120 · Practice › Dosing & titration · 10 Jul 2024 · 0 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #11 · Nutrition & Training › Resistance training · 15 Jun 2024 · 15 likes Picking up post #9: that is the part I would want checked first. Reduced appetite makes fuelling a session harder, and that is a practical problem with practical…